CLINICAL_TRIALS
withdrawal
· 2014-01-22
Clinical Trial Update: RU-486 in the Treatment of Bipolar Depression [Phase 2]
Summary
A Phase 2 trial of RU-486 (mifepristone) for bipolar depression has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of British Columbia | Conditions: Bipolar Depression | Phase 2 | Status: WITHDRAWN